These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16128268)

  • 1. [Therapeutic vaccination against chronic hepatitis B virus infection].
    Mancini-Bourgine M; Michel ML
    Therapie; 2005; 60(3):257-65. PubMed ID: 16128268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic vaccination against chronic hepatitis B virus infection.
    Michel ML; Mancini-Bourgine M
    J Clin Virol; 2005 Dec; 34 Suppl 1():S108-14. PubMed ID: 16461209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards immunotherapy for chronic hepatitis B virus infections.
    Michel ML
    Vaccine; 2002 Dec; 20 Suppl 4():A83-8. PubMed ID: 12477434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future.
    Michel ML; Pol S; Brechot C; Tiollais P
    Vaccine; 2001 Mar; 19(17-19):2395-9. PubMed ID: 11257367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic vaccination in chronic hepatitis B virus carriers.
    Pol S; Michel ML
    Expert Rev Vaccines; 2006 Oct; 5(5):707-16. PubMed ID: 17181443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
    Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection.
    Webster G; Bertoletti A
    Mol Immunol; 2001 Dec; 38(6):467-73. PubMed ID: 11741696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory therapy for chronic hepatitis B virus infection.
    Sprengers D; Janssen HL
    Fundam Clin Pharmacol; 2005 Feb; 19(1):17-26. PubMed ID: 15660957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
    Roggendorf M; Schulte I; Xu Y; Lu M
    J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic vaccination for treatment of chronic hepatitis B.
    Cargill T; Barnes E
    Clin Exp Immunol; 2021 Aug; 205(2):106-118. PubMed ID: 33969474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.
    Michel ML; Loirat D
    Intervirology; 2001; 44(2-3):78-87. PubMed ID: 11509869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy and therapeutic vaccines for chronic HBV infection.
    Lang-Meli J; Neumann-Haefelin C; Thimme R
    Curr Opin Virol; 2021 Dec; 51():149-157. PubMed ID: 34710645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lack of effect of therapeutic vaccination with a pre-S2/S HBV vaccine in the immune tolerant phase of chronic HBV infection.
    Yalcin K; Danis R; Degertekin H; Alp MN; Tekes S; Budak T
    J Clin Gastroenterol; 2003 Oct; 37(4):330-5. PubMed ID: 14506391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck.
    Kosinska AD; Liu J; Lu M; Roggendorf M
    Med Microbiol Immunol; 2015 Feb; 204(1):103-14. PubMed ID: 25535101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?
    Beckebaum S; Cicinnati VR; Gerken G
    Rev Med Virol; 2002; 12(5):297-319. PubMed ID: 12211043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
    Couillin I; Pol S; Mancini M; Driss F; Bréchot C; Tiollais P; Michel ML
    J Infect Dis; 1999 Jul; 180(1):15-26. PubMed ID: 10353856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.
    Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Bréchot C; Michel ML
    Hepatology; 2004 Oct; 40(4):874-82. PubMed ID: 15382173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
    Mancini-Bourgine M; Fontaine H; Bréchot C; Pol S; Michel ML
    Vaccine; 2006 May; 24(21):4482-9. PubMed ID: 16310901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.